V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330002767 | 330001493 | 1.6 | 72.8 | null | 2017-12-04 | 2017-12-20 | BENDAMUSTINE + RITUXIMAB | N | N | 330011386 | BENDAMUSTINE + RITUXIMAB |
| 330002768 | 330001494 | 1.64 | null | Curative (C) | 2015-08-21 | 2015-08-27 | BENDAMUSTINE + RITUXIMAB | 2 | N | 330011387 | BENDAMUSTINE + RITUXIMAB |
| 330002769 | 330006795 | 1.65 | 60.4 | Neo-adjuvant (N) | 2017-07-13 | 2017-07-15 | Cisplatin + Doxorubicin | N | N | 330011392 | CISPLATIN + DOXORUBICIN |
| 330002770 | 330001495 | 1.8 | null | Palliative (P) | 2017-07-16 | 2017-07-16 | Carboplatin + Etoposide iv&po | 01 | N | 330011406 | CARBOPLATIN + ETOPOSIDE |
| 330002771 | 330001495 | 1.78 | 47.2 | Palliative (P) | 2017-03-22 | 2017-03-22 | Liposomal Doxorubicin (Caelyx) | N | N | 330011406 | LIPOSOMAL DOXORUBICIN |
| 330002772 | 330001495 | 1.67 | 38 | Palliative (P) | 2016-09-06 | 2016-09-07 | Cisplatin + Doxorubicin | Y | N | 330011406 | CISPLATIN + DOXORUBICIN |
| 330002773 | 330001495 | 1.58 | 77.5 | Palliative (P) | 2018-02-13 | 2018-02-27 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330011406 | CARBOPLATIN + PACLITAXEL |
| 330002774 | 330001495 | null | 87.6 | Palliative (P) | 2015-07-30 | 2015-08-18 | Doxorubicin 75mg/m2 | N | N | 330011406 | DOXORUBICIN |
| 330002775 | 330001495 | 1.7 | null | Neo-adjuvant (N) | 2015-02-27 | 2015-03-04 | Carboplatin AUC 2 - 5 | N | N | 330011406 | CARBOPLATIN |
| 330002776 | 330001495 | 1.57 | 89.5 | Curative (C) | 2018-12-21 | 2018-12-26 | Rituximab | 02 | N | 330011406 | RITUXIMAB |
| 330002777 | 330001496 | null | 67.5 | Palliative (P) | 2014-01-08 | 2014-01-28 | Liposomal Doxorubicin (Caelyx) | N | N | 330011440 | LIPOSOMAL DOXORUBICIN |
| 330002778 | 330001497 | 1.72 | 70.2 | Neo-adjuvant (N) | 2017-04-23 | 2017-05-07 | Cisplatin + Doxorubicin | N | N | 330011441 | CISPLATIN + DOXORUBICIN |
| 330002779 | 330001497 | 1.66 | 82.6 | Curative (C) | 2015-08-20 | 2015-09-21 | CARBOPLATIN | 2 | N | 330011441 | CARBOPLATIN |
| 330002780 | 330001497 | 1.83 | null | Palliative (P) | 2017-05-11 | 2017-06-08 | Carboplatin + Etoposide IV 3 day | N | N | 330011441 | CARBOPLATIN + ETOPOSIDE |
| 330002781 | 330001497 | 1.77 | 60.5 | Neo-adjuvant (N) | 2016-08-16 | 2016-08-18 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330011441 | CARBOPLATIN + PACLITAXEL |
| 330002782 | 330001497 | 1.62 | null | Neo-adjuvant (N) | 2016-10-19 | 2016-10-19 | Cisplatin + Doxorubicin | 02 | N | 330011441 | CISPLATIN + DOXORUBICIN |
| 330002783 | 330001497 | 1.63 | 65 | Curative (C) | 2013-06-09 | 2013-06-09 | CARBOPLATIN | N | N | 330011441 | CARBOPLATIN |
| 330002784 | 330001497 | 1.65 | 69.9 | Palliative (P) | 2016-05-26 | 2016-05-26 | Rituximab | 02 | N | 330011441 | RITUXIMAB |
| 330002785 | 330001497 | 1.71 | 75.1 | null | 2013-10-19 | 2013-11-03 | Cisplatin + Doxorubicin | N | N | 330011441 | CISPLATIN + DOXORUBICIN |
| 330002786 | 330001498 | 1.8 | 77.5 | Palliative (P) | 2017-04-26 | 2017-04-27 | Doxorubicin 75mg/m2 | 2 | N | 330011461 | DOXORUBICIN |
| 330002787 | 330001498 | 1.8 | 98 | Curative (C) | 2017-07-26 | 2017-07-27 | Rituximab | N | N | 330011461 | RITUXIMAB |
| 330002788 | 330001499 | 1.81 | 73.7 | Palliative (P) | 2017-10-12 | 2017-10-12 | CARBOPLATIN + PACLITAXEL | 02 | N | 330011465 | CARBOPLATIN + PACLITAXEL |
| 330002789 | 330001500 | 1.8 | 100 | Not known (9) | 2014-07-12 | 2014-07-19 | Bendamustine+Rituximab (1st Course) | 02 | N | 330011466 | BENDAMUSTINE + RITUXIMAB |
| 330002790 | 330001500 | 1.69 | 75 | Disease modification (D) | 2014-12-07 | 2014-12-10 | Rituximab | N | N | 330011466 | RITUXIMAB |
| 330002791 | 330001500 | 1.8 | 47.2 | Palliative (P) | 2018-01-29 | 2018-01-29 | CARBOPLATIN + PACLITAXEL | N | N | 330011466 | CARBOPLATIN + PACLITAXEL |
| 330002792 | 330001500 | 1.63 | null | Palliative (P) | 2016-04-27 | 2016-04-27 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330011466 | BENDAMUSTINE + RITUXIMAB |
| 330002793 | 330001500 | 1.73 | 83.8 | Neo-adjuvant (N) | 2016-03-31 | 2016-04-09 | Cisplatin + Doxorubicin | N | N | 330011466 | CISPLATIN + DOXORUBICIN |
| 330002794 | 330001501 | 1.61 | 63.7 | Neo-adjuvant (N) | 2016-07-08 | 2016-07-09 | Carboplatin AUC 6 - 10 | 02 | N | 330011479 | CARBOPLATIN |
| 330002795 | 330001502 | 1.7 | 110 | Palliative (P) | 2014-11-10 | 2014-11-10 | DOXORUBICIN | 02 | N | 330011480 | DOXORUBICIN |
| 330002796 | 330001503 | null | 86 | Palliative (P) | 2016-03-04 | 2016-03-12 | CNS GCT II Germinoma - Carbo Etop | null | N | 330011481 | CARBOPLATIN + ETOPOSIDE |
| 330002797 | 330006800 | 1.69 | 77.9 | Disease modification (D) | 2015-02-04 | 2015-02-05 | BENDAMUSTINE + RITUXIMAB | 2 | N | 330011485 | BENDAMUSTINE + RITUXIMAB |
| 330002798 | 330006800 | 1.72 | 89 | Disease modification (D) | 2015-01-19 | 2015-01-23 | BENDAMUSTINE + RITUXIMAB | 2 | N | 330011485 | BENDAMUSTINE + RITUXIMAB |
| 330002800 | 330001504 | 1.61 | 99.6 | null | 2014-08-10 | 2014-08-11 | Bendamustine+Rituximab (1st Course) | N | N | 330011489 | BENDAMUSTINE + RITUXIMAB |
| 330002801 | 330001504 | 1.8 | 83.9 | Neo-adjuvant (N) | 2016-05-17 | 2016-05-26 | Liposomal Doxorubicin (Caelyx) | 02 | N | 330011489 | LIPOSOMAL DOXORUBICIN |
| 330002802 | 330001505 | 1.66 | 71.3 | Not known (9) | 2014-05-03 | 2014-05-03 | LIPOSOMAL DOXORUBICIN | 2 | null | 330011497 | LIPOSOMAL DOXORUBICIN |
| 330002803 | 330001506 | 1.66 | 80.8 | Neo-adjuvant (N) | 2014-01-25 | 2014-02-09 | Cisplatin + Doxorubicin | N | N | 330011499 | CISPLATIN + DOXORUBICIN |
| 330002804 | 330001507 | 1.7 | 83 | Palliative (P) | 2016-08-24 | 2016-09-03 | Liposomal Doxorubicin (Caelyx) | N | N | 330011502 | LIPOSOMAL DOXORUBICIN |
| 330002805 | 330001508 | 1.67 | null | Neo-adjuvant (N) | 2017-03-03 | 2017-03-11 | Carboplatin AUC 2 - 5 | 02 | N | 330011506 | CARBOPLATIN |
| 330002806 | 330001509 | null | null | Curative (C) | null | 2013-08-26 | Liposomal Doxorubicin (Caelyx) | Y | null | 330011507 | LIPOSOMAL DOXORUBICIN |
| 330002807 | 330001510 | 1.78 | 90 | Adjuvant (A) | 2017-02-17 | 2017-03-09 | CARBOPLATIN + PACLITAXEL | N | N | 330011508 | CARBOPLATIN + PACLITAXEL |
| 330002808 | 330001511 | 1.63 | 87 | Not known (9) | 2017-08-18 | 2017-08-18 | CARBOPLATIN | 02 | N | 330011513 | CARBOPLATIN |
| 330002809 | 330001512 | 1.79 | 92.6 | Palliative (P) | 2014-09-15 | 2014-10-04 | DOXORUBICIN | N | N | 330011517 | DOXORUBICIN |
| 330002810 | 330001513 | 1.88 | 65.6 | Palliative (P) | 2013-03-03 | 2013-03-05 | DOXORUBICIN | N | N | 330011521 | DOXORUBICIN |
| 330002811 | 330006802 | 1.75 | 60.7 | Curative (C) | null | 2017-05-09 | Carboplatin + Etoposide iv&po | null | null | 330011522 | CARBOPLATIN + ETOPOSIDE |
| 330002812 | 330001514 | 1.58 | 63.7 | Adjuvant (A) | 2015-01-09 | 2015-01-25 | Cisplatin + Doxorubicin | N | N | 330011524 | CISPLATIN + DOXORUBICIN |
| 330002813 | 330001515 | 1.73 | null | Curative (C) | 2015-01-27 | 2015-02-02 | Cisplatin + Doxorubicin | N | N | 330011525 | CISPLATIN + DOXORUBICIN |
| 330002814 | 330001515 | 1.58 | 72.1 | Palliative (P) | 2015-11-03 | 2015-11-23 | Bendamustine+Rituximab (1st Course) | N | N | 330011525 | BENDAMUSTINE + RITUXIMAB |
| 330002815 | 330001516 | 1.57 | 67.1 | Neo-adjuvant (N) | 2013-12-09 | 2013-12-25 | Cisplatin + Doxorubicin | N | N | 330011529 | CISPLATIN + DOXORUBICIN |
| 330002816 | 330006804 | 1.57 | 63.4 | Not known (9) | 2017-12-09 | 2017-12-09 | BENDAMUSTINE + RITUXIMAB | 2 | N | 330011532 | BENDAMUSTINE + RITUXIMAB |
| 330002817 | 330001517 | 1.71 | 132.6 | Curative (C) | 2015-07-24 | 2015-07-29 | Doxorubicin 75mg/m2 | N | N | 330011544 | DOXORUBICIN |